Table 1 The characteristics of the study population

Recipient age^b

42.4 ± 12.66

Occupation^a

Unemployed 81 (71.1%)

Non professional 16 (14%)

Professional 17 (14.9%)

Donor type^a

Living related donor: 99 (86.8%)

Living unrelated: 15 (13.2%)

History of acute rejection^a

Yes 13 (11.4%) No 101 (88.6%)

Donor age (years)^b

28.9 ± 7.6

Use of EPO pre-transplant^a

Yes 64 (56.1%) No 50 (43.9%)

Use of Mycofenolate mofetil^a

Yes 31 (27.2%) No 83(72.8%)

Use of Azathioprine^a

Yes 80 (70.2%) No 34 (29.8%)

Use of Cyclosporine^a

Yes 45 (39.5%) No 69 (60.5%)

Use of Tacrolimus^a

Yes 65 (57%) No 49 (43%)

Use of ACEI/ARB^a

Yes 23 (20.2%) No 91 (79.8%)

Co-morbidities

Yes 9 (7.9%) No 105 (92%)

Time on Dialysis (months)^b

14.6 ± 13

Period of kidney transplantation (months)^b

49 ± 42.26

Hb g/dl^b

12.7 ± 1.96

Creatinine mg/dl^b

1.4 ± 0.88

Urea mg/dl^b

39.17 ± 19.5

eGFR ml/min/1.73^{2 b}

81.6 ± 34.3